-
公开(公告)号:US20070043001A1
公开(公告)日:2007-02-22
申请号:US10554001
申请日:2004-04-20
申请人: Mark Bilodeau , Mark Duggan , John Hartnett , Craig Lindsley , Zhicai Wu , Zhijian Zhao
发明人: Mark Bilodeau , Mark Duggan , John Hartnett , Craig Lindsley , Zhicai Wu , Zhijian Zhao
IPC分类号: A61K31/4545 , A61K31/675 , C07D401/02 , C07F9/59
CPC分类号: C07F9/65583 , A61K45/06 , C07D401/04 , C07D401/14 , C07D413/04 , C07D413/14 , C07D417/14 , C07D487/04
摘要: The present invention is directed to compounds which contain a substituted pyridine moeity which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
摘要翻译: 本发明涉及含有抑制Akt(丝氨酸/苏氨酸蛋白激酶)活性的取代吡啶甲氧基化合物。 本发明还涉及含有本发明化合物的治疗组合物和治疗癌症的方法,包括施用本发明化合物。
-
公开(公告)号:US20050222155A1
公开(公告)日:2005-10-06
申请号:US10510069
申请日:2003-04-04
申请人: Mark Bilodeau , Mark Duggan , John Hartnett , Craig Lindsley , Peter Manley , Zhicai Wu , Zhijian Zhao
发明人: Mark Bilodeau , Mark Duggan , John Hartnett , Craig Lindsley , Peter Manley , Zhicai Wu , Zhijian Zhao
IPC分类号: C07D333/56 , A61K31/138 , A61K31/337 , A61K31/4535 , A61K31/4545 , A61K31/4709 , A61K31/498 , A61K31/4985 , A61K31/52 , A61K31/706 , A61K45/00 , A61P5/30 , A61P9/14 , A61P35/00 , A61P43/00 , C07D305/14 , C07D401/10 , C07D401/12 , C07D401/14 , C07D403/10 , C07D403/14 , C07D409/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D519/00 , C07H5/06 , C07H17/02 , C07D215/12
CPC分类号: C07D401/10 , A61K31/498 , C07D401/12 , C07D401/14 , C07D403/10 , C07D403/14 , C07D409/14 , C07D417/14 , C07D471/04
摘要: The present invention is directed to compounds comprising a 2,3-diphenylquinoxaline moiety which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
-
公开(公告)号:US20070082906A1
公开(公告)日:2007-04-12
申请号:US10554186
申请日:2004-04-20
申请人: Mark Bilodeau , Craig Lindsley , Zhijian Zhao
发明人: Mark Bilodeau , Craig Lindsley , Zhijian Zhao
IPC分类号: A61K31/53 , C07D403/02
CPC分类号: C07D417/14 , C07D253/065 , C07D401/14 , C07D405/14 , C07D409/14 , C07D413/14
摘要: The present invention is directed to compounds which contain a heterocyclic triazine moiety which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
摘要翻译: 本发明涉及含有抑制Akt(丝氨酸/苏氨酸蛋白激酶)活性的杂环三嗪部分的化合物。 本发明还涉及含有本发明化合物的治疗组合物和治疗癌症的方法,包括施用本发明化合物。
-
公开(公告)号:US20070254901A1
公开(公告)日:2007-11-01
申请号:US11659606
申请日:2005-08-19
申请人: Mark Bilodeau , Nicolas Cosford , John Hartnett , Yiwei Li , Jun Liang , Peter Manley , Lou Neilson , Tony Siu , Zhicai Wu
发明人: Mark Bilodeau , Nicolas Cosford , John Hartnett , Yiwei Li , Jun Liang , Peter Manley , Lou Neilson , Tony Siu , Zhicai Wu
IPC分类号: A61K31/519 , A61P35/00 , C07D471/04
CPC分类号: C07D471/04
摘要: The present invention is directed to compounds which contain substituted 5-deazapteridine moieties which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
摘要翻译: 本发明涉及含有抑制Akt(丝氨酸/苏氨酸蛋白激酶)活性的取代的5-取代哌啶部分的化合物。 本发明还涉及含有本发明化合物的治疗组合物和治疗癌症的方法,包括施用本发明化合物。
-
公开(公告)号:US20060030595A1
公开(公告)日:2006-02-09
申请号:US11188466
申请日:2005-07-25
申请人: Mark Bilodeau , Christopher Dinsmore , Jeffrey Bergman , B. Trotter , Lou Neilson , Zhicai Wu , Peter Manley , John Hartnett
发明人: Mark Bilodeau , Christopher Dinsmore , Jeffrey Bergman , B. Trotter , Lou Neilson , Zhicai Wu , Peter Manley , John Hartnett
IPC分类号: A61K31/506 , A61K31/444 , C07D401/14 , C07D403/14
CPC分类号: C07D213/57 , C07D213/06 , C07D213/30 , C07D213/42 , C07D213/61 , C07D213/64 , C07D213/73 , C07D213/74 , C07D213/75 , C07D213/76 , C07D213/81 , C07D213/84 , C07D401/14 , C07D413/14 , C07D417/14
摘要: The present invention relates to compounds having the structure useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.
-
公开(公告)号:US20060205765A1
公开(公告)日:2006-09-14
申请号:US10554185
申请日:2004-04-20
申请人: Mark Bilodeau , Zhicai Wu
发明人: Mark Bilodeau , Zhicai Wu
IPC分类号: A61K31/4745 , C07D498/02 , C07D491/02 , C07D471/02
CPC分类号: C07D487/04 , C07D471/04
摘要: The present invention is directed to compounds which contain a five-membered heterocyclic ring fused to a substituted pyridine moiety which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
摘要翻译: 本发明涉及含有与取代的吡啶部分稠合的五元杂环的化合物,所述取代吡啶部分抑制丝氨酸/苏氨酸蛋白激酶Akt的活性。 本发明还涉及含有本发明化合物的治疗组合物和治疗癌症的方法,包括施用本发明化合物。
-
公开(公告)号:US20050176753A1
公开(公告)日:2005-08-11
申请号:US10512927
申请日:2003-04-28
申请人: Mark Bilodeau , Mark Fraley , Zhicai Wu
发明人: Mark Bilodeau , Mark Fraley , Zhicai Wu
IPC分类号: A61K31/09 , A61K31/4196 , A61K31/437 , A61K31/444 , A61K31/454 , A61K31/4545 , A61K31/4745 , A61K31/496 , A61K31/551 , A61K31/575 , A61K31/737 , A61K38/00 , A61K38/21 , A61P17/00 , A61P19/00 , A61P27/02 , A61P29/00 , A61P35/00 , C07D471/04
CPC分类号: C07D471/04
摘要: The present invention relates to imidazopyridine compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
摘要翻译: 本发明涉及抑制,调节和/或调节酪氨酸激酶信号转导的咪唑并吡啶化合物,含有这些化合物的组合物,及其用于治疗酪氨酸激酶依赖性疾病和病症如血管生成,癌症,肿瘤生长, 动脉粥样硬化,年龄相关性黄斑变性,糖尿病性视网膜病变,炎症性疾病等。
-
公开(公告)号:US20080090794A1
公开(公告)日:2008-04-17
申请号:US11658114
申请日:2005-07-27
申请人: Christoph Dinsmore , Jeffrey Bergman , Douglas Beshore , B. Wesley Trotter , Kausik Nanda , Richard Isaacs , Linda Payne , Lou Anne Neilson , Zhicai Wu , Mark Bilodeau , Peter Manley , Adrianne Balitza
发明人: Christoph Dinsmore , Jeffrey Bergman , Douglas Beshore , B. Wesley Trotter , Kausik Nanda , Richard Isaacs , Linda Payne , Lou Anne Neilson , Zhicai Wu , Mark Bilodeau , Peter Manley , Adrianne Balitza
IPC分类号: A61K31/5377 , A61K31/397 , A61K31/438 , A61K31/4412 , A61K31/4439 , A61P9/04 , C07D213/04 , C07D221/20 , C07D401/14 , C07D413/02 , C07D413/00 , C07D401/02 , C07D213/63 , A61P9/06 , A61P9/00 , A61K31/444 , A61K31/497 , A61K31/506
CPC分类号: C07D213/36 , C07D213/30 , C07D213/32 , C07D213/38 , C07D213/40 , C07D213/42 , C07D213/55 , C07D213/56 , C07D213/64 , C07D401/06 , C07D401/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D471/10 , C07D487/08 , C07D491/08
摘要: The present invention relates to compounds having the structure useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.
摘要翻译: 本发明涉及具有用作治疗心律失常的钾通道抑制剂的结构的化合物等。
-
公开(公告)号:US20050228031A1
公开(公告)日:2005-10-13
申请号:US10823156
申请日:2004-04-13
申请人: Mark Bilodeau , Leonard Rodman
发明人: Mark Bilodeau , Leonard Rodman
IPC分类号: A61K31/426 , C07D263/48 , C07D277/18 , C07D277/42 , C07D277/56 , C07D417/12
CPC分类号: C07D277/42 , C07D263/48 , C07D277/56 , C07D417/12
摘要: The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
摘要翻译: 本发明涉及抑制,调节和/或调节酪氨酸激酶信号转导的化合物,含有这些化合物的组合物及其用于治疗酪氨酸激酶依赖性疾病和病症如血管生成,癌症,肿瘤生长,动脉粥样硬化的方法 ,年龄相关性黄斑变性,糖尿病性视网膜病变,炎症性疾病等。
-
公开(公告)号:US07205737B1
公开(公告)日:2007-04-17
申请号:US11324818
申请日:2006-01-04
申请人: Mark Bilodeau
发明人: Mark Bilodeau
IPC分类号: H02K17/32
CPC分类号: H02P7/29 , H02H7/0833 , H02P29/02 , H02P29/67 , Y10S388/93
摘要: Systems and methods of detecting an overload condition. In one embodiment, a method of monitoring a load of a DC motor includes intermittently de-energizing the motor; monitoring a first voltage; and measuring a first interval of time between a starting time and an ending time, wherein the starting time comprises the time at which the motor is de-energized and the ending time comprises a time at which the first voltage and a reference voltage have substantially similar values.
摘要翻译: 检测过载条件的系统和方法。 在一个实施例中,监视直流电动机的负载的方法包括间歇地使电动机断电; 监测第一电压; 并且测量起始时间和结束时间之间的第一时间间隔,其中所述起动时间包括所述电动机断电的时间,并且所述结束时间包括所述第一电压和参考电压具有基本相似的时间 价值观。
-
-
-
-
-
-
-
-
-